NFκB anti-apoptotic or pro-apoptotic, maybe both

Cell Cycle

Volumn 9, Issue 16, 2010, Pages 3131-3132

  Martin, Angel G ^a  

^a Fundacion Inbiomed   (Spain)

Author keywords

Apoptosis; NF B; Noxa; p53; p73

Indexed keywords

BH3 PROTEIN; DAUNORUBICIN; DEATH RECEPTOR 5; DOXORUBICIN; FAS ANTIBODY; FIBROCYSTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOXANTRONE; ORIDONIN; P21 ACTIVATED KINASE; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P53; PROTEIN P63; PROTEIN P73; PUMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER THERAPY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; DNA DAMAGE; EDITORIAL; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SOLID TUMOR; STRESS;

EID: 77955720243     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.16.12780     Document Type: Editorial

References (10)

1. Ryan KM, et al. Nature 2000; 404:892-7.
2. Martin AG, et al. Aging 2009; 1:335-49.
3. O'Prey J, et al. Cell Cycle 2010; 9:947-52.
4. Karl S, et al. J Cell Mol Med 2009.
5. Mangolini A, et al. Apoptosis 15:94-104.
6. Zhang Y, et al. Arch Biochem Biophys 2009; 489:25-33.
7. Schneider G, et al. Oncogene 29:2795-806.
8. Bednarski BK, et al. PLoS One 2009; 4:6992.
9. Nakano K, et al. Mol Cell 2001; 7:683-94.
10. Wang P, et al. Cell Death Differ 2009; 16:1192-202.